| Russell B. Osteen Ch | |
|
1025 W Tunnel Blvd, Houma, LA 70360-4026 | |
| (985) 876-5790 | |
| (985) 876-9371 |
| Full Name | Russell B. Osteen Ch |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 1025 W Tunnel Blvd, Houma, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225255078 | NPI | - | NPPES |
| 1954357 | Medicaid | LA | |
| 421785413B | Other | LA | BLUE CROSS OF LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 880 (Louisiana) | Primary |
| Provider Name | Russell B Osteen |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1215960182 PECOS PAC ID: 1951407774 Enrollment ID: I20070510000369 |
News Archive
Fetal magnetic resonance imaging can reliably spot holoprosencephaly as early as 18 gestational weeks, providing an opportunity to counsel families earlier in their pregnancy, according to Children's-led research published online May 18, 2018, in the American Journal of Medical Genetics.
BioCryst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), has issued an emergency use authorization (EUA) for the investigational anti-viral drug intravenous (i.v.) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.
KQED's California Report/Health Dialogues reports on end-of-life care and the roles culture and insurance play. In considering end of life care, "sometimes there's disagreement within a family, and cultural and generational differences can complicate what is already an emotionally fraught situation.
With the launch of the country's first ever commercial genetic test for type 2 diabetes, Indians will now have access to clinically relevant and cost effective genetic risk assessment services. NutraGene, a Delhi based genomics company that launched the tests believes that its type 2 diabetes genetic test will provide physicians an effective tool in assessing the risk of diabetes in the Indian population and will help in implementing personalized prevention and management strategies.
The European Commission has granted marketing authorisation for Servier's Valdoxan/Thymanax (agomelatine), the first melatonergic antidepressant for the treatment of adult patients with major depressive episodes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Russell B. Osteen Ch 1025 W Tunnel Blvd, Houma, LA 70360-4026 Ph: (985) 876-5790 | Russell B. Osteen Ch 1025 W Tunnel Blvd, Houma, LA 70360-4026 Ph: (985) 876-5790 |
News Archive
Fetal magnetic resonance imaging can reliably spot holoprosencephaly as early as 18 gestational weeks, providing an opportunity to counsel families earlier in their pregnancy, according to Children's-led research published online May 18, 2018, in the American Journal of Medical Genetics.
BioCryst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), has issued an emergency use authorization (EUA) for the investigational anti-viral drug intravenous (i.v.) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.
KQED's California Report/Health Dialogues reports on end-of-life care and the roles culture and insurance play. In considering end of life care, "sometimes there's disagreement within a family, and cultural and generational differences can complicate what is already an emotionally fraught situation.
With the launch of the country's first ever commercial genetic test for type 2 diabetes, Indians will now have access to clinically relevant and cost effective genetic risk assessment services. NutraGene, a Delhi based genomics company that launched the tests believes that its type 2 diabetes genetic test will provide physicians an effective tool in assessing the risk of diabetes in the Indian population and will help in implementing personalized prevention and management strategies.
The European Commission has granted marketing authorisation for Servier's Valdoxan/Thymanax (agomelatine), the first melatonergic antidepressant for the treatment of adult patients with major depressive episodes.
› Verified 1 days ago
Melancon Chiropractic & Wellness Clinic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 430 Corporate Dr, Houma, LA 70360 Phone: 985-873-8586 Fax: 985-873-8565 | |
Houma Thibodaux Spine And Rehabilitation, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 430 Corporate Dr, Houma, LA 70360 Phone: 985-873-8586 Fax: 985-873-8565 | |
Family Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 205 Bayou Gardens Blvd Ste E1, Houma, LA 70364 Phone: 985-868-0037 Fax: 985-223-4478 | |
Holistic Health Medical Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 567 Corporate Dr, Houma, LA 70360 Phone: 985-223-3811 | |
Amy Redmond Rhodes, D. C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 106 Southdown West Blvd, Houma, LA 70360 Phone: 985-873-8100 Fax: 985-873-8159 | |
Dr. J.michael Flynn, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 567 Corporate Dr, Houma, LA 70360 Phone: 985-223-3811 Fax: 985-223-3877 | |
Dr. Russell B O'steen, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 1025 W Tunnel Blvd, Houma, LA 70360 Phone: 985-876-5790 Fax: 985-876-9371 |